Related Experiment Video
Updated: Sep 13, 2025
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Risk of heart failure and subtypes with biomarker-calibrated protein intake: Women's health initiative cohort study
Muhammad Baig1,2, Ali A Khan2, Miremad Moafi-Madani1
1Department of Epidemiology, Brown University School of Public Health, RI, USA.
Introduction:
Heart failure (HF) is a growing epidemic, with risk of HF with preserved ejection fraction (HFpEF) significantly higher in post-menopausal women compared to men. Data on its association with dietary protein intake is limited.
Methods:
To study the association of dietary protein intake with risk of HF and its subtypes in post-menopausal women, we included post-menopausal women from Women's Health Initiative's (WHI) HF cohort. Protein intake was assessed from the biomarker measurements in the WHI Nutrient Biomarker Study (WHI-NBS), and its calibration on Food-Frequency-Questionnaire (FFQ) based protein intake. Cox-proportional hazards regression analysis was used to study associations.
Results:
Total of 14,789 women were included with a mean age (SD) of 62 (7) years and follow-up of 14 (8) years. Participants were predominantly African American (48.5 %). Multivariable Cox-proportional hazards regression model adjusted for age, education, income, race/ethnicity, physical activity, smoking, alcohol, prevalent and incident CHD, hypertension, hyperlipidemia, and atrial fibrillation showed elevated risk of total incident hospitalized HF and HFpEF with higher intake of dietary protein across all quintiles (Q2-Q5) compared to Q1 in a dose-response relationship (HR of HF, Q5 compared to Q1: 2.26, 95 % CI: 1.66, 3.09, P<.0001; HR of HFpEF, Q5 compared to Q1: 2.50, 95 % CI 1.62, 3.84, P<.0001). When stratified by BMI, HF and HFpEF risk was elevated across quintiles of BMI > 30, indicating BMI may be an effect modifier.
Conclusion:
In conclusion, higher protein intake is associated with increased risk of HF and HFpEF, particularly in obese participants.
More Related Videos
07:44Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
01:30Coronary Artery Disease I: Introduction
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT